Kosiborod, M. N., Deanfield, J., Pratley, R., Borlaug, B. A., Butler, J., Davies, M. J., Emerson, S. S., Kahn, S. E., Kitzman, D. W., Lingvay, I., Mahaffey, K. W., Petrie, M. C., Plutzky, J., Rasmussen, S., Rönnbäck, C., Shah, S. J., Verma, S., Weeke, P. E., Lincoff, A. M., & SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM Trial Committees and Investigators. (2024). Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials. Lancet (London, England), S0140-6736(24)01643-X. Advance online publication. https://doi.org/10.1016/S0140-6736(24)01643-X
